Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
about
Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniquesAssociation of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risksDifferent ovarian stimulation protocols for women with diminished ovarian reserveFSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programsPoor ovarian reserveLow-dose aspirin for in vitro fertilization: a systematic review and meta-analysisThe effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization.Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers.Management of poor responders in IVF: is there anything new?Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.Patient scheduling for gonadotrophin-releasing hormone antagonist protocols.Are poor responders patients at higher risk for producing aneuploid embryos in vitro?Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome?Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy.A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF.A chromosome 19 locus positively influences the number of retrieved oocytes during stimulated cycles in Brazilian womenA simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturationManagement of the poor responder: the role of GnRH agonists and antagonistsEffectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up.Treatment-associated serum FSH levels in very poor responders to ovarian stimulation.Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF.Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVFCessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor respondersWhat should be the maximum FSH dose in IVF/ICSI in poor responders?Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patientsPrediction and diagnosis of poor ovarian response: the dilemma.Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders.Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm InjectionMicrodose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization?Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study.Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF).Effectiveness of the antagonist/letrozole protocol for treating poor responders undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase: A Randomized Controlled Trial.Clinical predictors of failing one dose of methotrexate for ectopic pregnancy after in vitro fertilization.Combined evaluation of risk factors predicting poor ovarian responders in Chinese patients undergoing in vitro fertilization.Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel's back.
P2860
Q24240361-41A31D33-79C5-4117-B85B-628993C3A925Q24240409-B1BD7BFE-9275-41E4-AD5E-82AB9DC9DFAEQ24621546-CAD9BE65-B3EE-4212-BE1E-F3BB9AAF1CBFQ24634342-4294122E-4593-4015-98DA-3AB57C6117A7Q24634373-D722D2FA-3080-45C9-B108-F3DDF8675B2CQ26744379-D2F3791B-9A0D-4D90-BFB9-B8FC6AB5E74AQ28220366-36A5F6E9-D7A3-4241-BCBD-038411E4B31FQ33686491-6BE888CB-705E-442E-B5B0-14BE864FF835Q33992236-29AC05D6-21C1-4A5A-95DC-3190457B58F5Q34022512-FB9D4448-8842-4926-A203-54E7CEC62146Q34082122-794E9B4C-E9A4-4174-A2D7-10BF6A1AACA8Q34568492-087614DB-6D14-4F02-B743-2C1A47207C9EQ34591678-DA699B4E-88E9-414C-AD58-3E154A716B65Q35151104-93738F53-7EC1-48AE-AABC-A2C0AE6871C8Q35553163-EE195E83-A2BE-4EF2-ADEE-D8D7899D1FD4Q35700751-7C865553-D094-4E01-BEB1-58B4E2EE931EQ35804563-2897350C-D619-486E-9E66-5CE3CEB3288EQ35946624-483AD113-4541-4FDF-B8FC-CA51E0B191F2Q36247244-16930378-3EB0-438E-9E75-EEDC5945C431Q36268626-37152FC4-3842-49EC-8794-89ED6B7F69FEQ36269268-846A7357-1F98-4C06-B21F-5CD8A5B77328Q36269309-BAC91EC6-9BA8-4EFF-B58E-25F9C2E888F0Q36270555-87C367E2-0EC9-4567-A16C-E7D95EAD578CQ36270584-A9756DAC-D69E-487A-8AFD-CB92EED072AEQ36271243-DB15C42E-8133-41A7-88FD-F2ED4B13C436Q36271341-3E1961BF-6876-41CE-A4EE-A2F5F3166F54Q36892424-E7BB18B8-BBD2-439D-BD44-BBE173D54887Q36970328-E280820E-4963-4408-8F22-C3EA0FD46F24Q37035196-B370E548-BE70-4FB5-ADEA-93C4FB49316CQ37035354-C6E07F91-F5EB-4D51-8FDC-8E3881908FADQ37099563-D27DD89D-EFD3-46FF-9D0E-6EEC3BFF0A89Q37116986-07185814-850B-4415-894F-D68FF9EB63B4Q37611176-E1455A47-8E8B-4E59-BE0A-F01849A77875Q37942272-7396AF56-F430-452D-BE55-3BA9D6864B27Q38181172-A048771F-52A1-4C0B-9FC7-C189B2C290A9Q38765739-ABF148D5-C71C-4491-BF80-4016C3354CF8Q39202983-9F214170-EF19-4243-8CE8-B4E88EDFBC63Q40393438-0085C2B4-EA32-4714-A7FC-BADF453C66E8Q40405658-1F5A979F-0213-4050-B0F0-40613C8ADE3DQ42375163-F3B14B96-5EBB-44E5-8D00-53C8F02A97FD
P2860
Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@en
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@nl
type
label
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@en
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@nl
prefLabel
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@en
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@nl
P2093
P1476
Clinical and endocrine effects ...... rgoing in vitro fertilization.
@en
P2093
P304
P356
10.1016/S0015-0282(97)00575-X
P407
P577
1998-03-01T00:00:00Z